Thoracic Imaging

What Is the Best Initial Imaging for Acute Deterioration in Diffuse Lung Disease?

·
What Is the Best Initial Imaging for Acute Deterioration in Diffuse Lung Disease?

A 68-year-old patient with a known diagnosis of idiopathic pulmonary fibrosis (IPF) presents to the emergency department with three days of worsening shortness of breath and a new, dry cough. Their oxygen saturation has dropped from a baseline of 92% on 2 liters to 88% on 4 liters. You suspect an acute exacerbation or a superimposed process like pneumonia. As you consider the initial workup, the immediate question is which imaging study to order first to guide management without delay. This article provides a clinical workflow for this specific scenario, grounded in the American College of Radiology (ACR) Appropriateness Criteria, which rate a chest radiograph as Usually Appropriate for the initial evaluation.

Who Fits This Clinical Scenario?

This guidance applies to a specific patient population: individuals with a previously confirmed diagnosis of diffuse lung disease (DLD) who are now experiencing an acute clinical deterioration. This includes conditions such as idiopathic pulmonary fibrosis (IPF), nonspecific interstitial pneumonia (NSIP), chronic hypersensitivity pneumonitis, or pulmonary sarcoidosis. The key features of the presentation are a new or accelerated worsening of respiratory symptoms, such as dyspnea, cough, or fatigue, often accompanied by increased oxygen requirements or new findings on physical examination like crackles.

This workflow is distinct from other related clinical situations. It does not apply to:

  • Patients with suspected but not yet diagnosed DLD. The initial diagnostic workup for a patient presenting with signs of DLD for the first time follows a different imaging pathway, often starting with high-resolution computed tomography (HRCT).
  • Patients with confirmed DLD who are clinically stable. Routine, scheduled follow-up imaging for monitoring disease progression in an asymptomatic or stable patient is a separate scenario with different recommendations.

The focus here is strictly on the urgent, initial imaging choice when a patient with known DLD takes a sudden turn for the worse.

What Diagnoses Are You Working Up in This Scenario?

When a patient with established diffuse lung disease deteriorates, the differential diagnosis is broad, and the goal of initial imaging is to rapidly identify treatable causes. The primary considerations include infection, a primary disease flare, and other acute pulmonary complications.

Infection: A superimposed infection, such as community-acquired pneumonia (bacterial or viral), is one of the most common triggers for acute decompensation. Patients with DLD, particularly those on immunosuppressive therapy, are at higher risk. Imaging helps identify new consolidations or ground-glass opacities that suggest an infectious etiology.

Acute Exacerbation of Interstitial Lung Disease (AE-ILD): This is an acute, clinically significant respiratory deterioration of unknown cause. It represents an acceleration of the underlying fibrotic process and carries a high mortality rate. Imaging may show new, widespread ground-glass opacities or consolidation superimposed on the pre-existing pattern of fibrosis. It is often a diagnosis of exclusion after infection and other causes have been ruled out.

Pulmonary Edema: Differentiating cardiogenic pulmonary edema from an ILD exacerbation can be challenging, as both can present with worsening dyspnea and new opacities on imaging. Patients with DLD often have comorbid cardiac conditions, including pulmonary hypertension. Imaging findings like pleural effusions, Kerley B lines, and cardiomegaly may point toward a cardiac cause.

Pneumothorax: Spontaneous pneumothorax is a known complication of advanced fibrotic lung diseases due to the formation of cysts and bullae. It can cause a sudden and severe decline and is a critical diagnosis to make quickly, as it requires immediate intervention.

Pulmonary Embolism (PE): While less common, PE should be considered, especially in patients with risk factors like immobility or underlying malignancy. The clinical presentation can overlap significantly with an AE-ILD. This diagnosis typically requires contrast-enhanced CT for confirmation.

Why Is a Chest Radiograph the Recommended First Study?

For the initial imaging of a patient with confirmed diffuse lung disease and suspected acute deterioration, the ACR designates a chest radiograph as Usually Appropriate. This recommendation is based on a balance of diagnostic utility, accessibility, speed, and safety.

A chest radiograph is an excellent first-line tool because it is rapidly available in nearly all clinical settings and provides crucial information with very low radiation exposure (adult relative radiation level ☢ <0.1 mSv). It can reliably detect many of the critical, treatable causes of acute deterioration. A radiograph can readily identify a large pneumothorax, significant pleural effusions, overt pulmonary edema, or dense lobar consolidation suggestive of bacterial pneumonia. Comparing the new radiograph to prior studies is essential for detecting interval changes against the backdrop of chronic fibrosis.

While a chest radiograph is the recommended starting point, the ACR also rates CT chest without IV contrast as Usually Appropriate. A non-contrast CT provides far greater detail of the lung parenchyma than a radiograph. It is superior for detecting subtle new ground-glass opacities, which may be the only sign of an early infection or an acute exacerbation (AE-ILD). In many cases, if the chest radiograph is negative or non-diagnostic but clinical suspicion for an acute process remains high, a non-contrast CT is the logical next step.

Other modalities are rated lower for this specific initial workup:

  • CT chest with IV contrast is rated as May be appropriate. It is not the standard first choice because the primary differential diagnoses (infection, AE-ILD) do not require intravenous contrast for evaluation. Contrast is reserved for cases where there is a specific clinical suspicion for pulmonary embolism, aortic dissection, or other vascular pathology.
  • MRI chest (with or without contrast) is rated as Usually not appropriate. MRI has limited utility in evaluating the lung parenchyma due to motion artifact and lower spatial resolution compared to CT. It is not a primary tool for assessing acute changes in DLD.

What’s Next After a Chest Radiograph? Downstream Workflow

The results of the initial chest radiograph will guide the subsequent clinical and diagnostic pathway. The workflow is a decision tree based on whether the findings are definitive, negative, or indeterminate.

If the radiograph is positive and definitive: If the study clearly shows a cause for deterioration, such as a large pneumothorax, lobar consolidation, or signs of florid pulmonary edema, the next step is targeted treatment. A pneumothorax may require chest tube placement, consolidation prompts initiation of antibiotics, and edema requires diuresis and cardiac management. Further advanced imaging may not be immediately necessary.

If the radiograph is negative or non-contributory: A normal or unchanged radiograph in a deteriorating patient is a significant finding that should raise suspicion for a process not well visualized on plain films. This is a common scenario, as early AE-ILD or subtle infections can be radiographically occult. The next step is typically to proceed to a CT chest without IV contrast. This higher-resolution study is essential to look for new ground-glass opacities or subtle consolidations that would confirm an acute parenchymal process and help differentiate infection from AE-ILD.

If the radiograph is indeterminate or shows non-specific changes: Often, there may be subtle new opacities that are difficult to characterize or distinguish from the patient’s extensive baseline fibrosis. In this situation, similar to a negative radiograph, the next step is a non-contrast chest CT to better delineate the acute process. If the clinical picture is at all suggestive of pulmonary embolism (e.g., pleuritic chest pain, unexplained tachycardia), a CT with IV contrast (CT angiography) would be the appropriate choice instead.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of an acutely deteriorating DLD patient requires careful consideration to avoid common diagnostic traps.

  • Over-reliance on the chest radiograph: Do not let a “negative” or “unchanged” chest X-ray dissuade you from further investigation if the patient is clinically worsening. Early or subtle parenchymal changes of AE-ILD or infection are frequently missed on plain films.
  • Attribution error: Avoid attributing all new symptoms solely to a progression of the underlying DLD. Always actively rule out superimposed, treatable conditions like infection, heart failure, or pneumothorax first.
  • Forgetting the baseline: Always compare the new imaging to the most recent prior studies. What appears to be a new opacity may be a stable scar, and subtle changes are only appreciated with direct comparison.
  • Delaying advanced imaging: In a rapidly deteriorating patient, consider proceeding directly to CT chest after an inconclusive radiograph rather than waiting. Time is critical, especially when considering AE-ILD.

If the patient shows signs of severe respiratory failure, hemodynamic instability, or if the diagnosis remains unclear after initial imaging, immediate consultation with a pulmonologist and/or critical care specialist is warranted.

Related ACR Topics and Tools

For a comprehensive overview of imaging recommendations across all clinical presentations of diffuse lung disease, please consult our parent guide. For additional resources to help refine your imaging orders, the following tools are available.

Frequently Asked Questions

Why not order a CT scan first for every patient with acute deterioration?

While a CT scan provides more detail, a chest radiograph is faster, more accessible, uses significantly less radiation, and is sufficient to diagnose many critical conditions like a large pneumothorax or florid pneumonia. The ACR recommends a stepwise approach, starting with a chest radiograph and proceeding to CT if the radiograph is negative or inconclusive in a clinically deteriorating patient.

When should I order a CT with intravenous contrast in this scenario?

A CT with IV contrast is rated ‘May be appropriate’ and should be reserved for situations where there is a specific clinical suspicion for a condition that requires it, most commonly pulmonary embolism (PE). If the patient presents with pleuritic chest pain, syncope, or unexplained tachycardia, a CT angiogram to rule out PE would be the correct choice over a non-contrast study.

What is the role of high-resolution CT (HRCT) in an acute exacerbation?

High-resolution CT (HRCT) refers to a specific technique with thin slices and a sharp reconstruction algorithm used to diagnose and characterize interstitial lung disease. In the acute setting, a standard non-contrast chest CT is typically sufficient to identify new ground-glass opacities or consolidation. While HRCT technique can be used, the priority is a rapid standard CT to assess for any acute process.

How does imaging help differentiate an infection from an acute exacerbation of ILD (AE-ILD)?

The imaging findings can overlap significantly, with both conditions causing new ground-glass opacities or consolidation. However, certain patterns may be more suggestive. A focal, lobar consolidation is more typical of bacterial pneumonia. Diffuse, bilateral ground-glass opacities superimposed on existing fibrosis are classic for AE-ILD. Ultimately, AE-ILD is a diagnosis of exclusion, and patients are often treated empirically with antibiotics while further workup, such as bronchoscopy, is considered.

If the patient is on immunosuppressants, does that change the initial imaging choice?

No, the initial imaging choice remains a chest radiograph. However, a patient’s immunosuppressed status increases the clinical suspicion for infection, including opportunistic pathogens. This context makes it even more critical to have a low threshold to proceed to a non-contrast chest CT if the radiograph is unrevealing, as these patients are at high risk for severe pneumonia.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026